The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -52.98%.However, over the last six months, we can see a stronger performance of -64.29%. Over the last 30 days, the price of RCKT has leaped by -32.53%. And in the last five days, it has surged by 13.87%.
Rocket Pharmaceuticals Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $26.98 on 07/26/24 and the lowest value was $4.55 on 04/09/25.
52-week price history of RCKT Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Rocket Pharmaceuticals Inc’s current trading price is -78.09% away from its 52-week high, while its distance from the 52-week low is 29.89%. The stock’s price range during this period has varied between$4.55 and $26.98. The Rocket Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 3.62 million for the day, a figure considerably higher than their average daily volume of 2.11 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Rocket Pharmaceuticals Inc (RCKT) has experienced a quarterly decline of -44.92% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 630.18M and boasts a workforce of 299 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.34, with a change in price of -8.07. Similarly, Rocket Pharmaceuticals Inc recorded 1,890,684 in trading volume during the last 100 days, posting a change of -57.73%.
RCKT’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RCKT stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.05.
RCKT Stock Stochastic Average
Rocket Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 19.71%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 32.00%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 19.19% and 15.08%, respectively.
